{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:08:20Z","timestamp":1787497700818,"version":"build-2736575974"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,21]],"date-time":"2018-08-21T00:00:00Z","timestamp":1534809600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,8,21]],"date-time":"2018-08-21T00:00:00Z","timestamp":1534809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Resistin plays a role in the growth, proliferation, angiogenesis, metastasis and therapeutic resistance in different cancers. However, such effects of resistin have never been evaluated in ovarian cancer, a deadly gynecological malignancy. We observed a significant induction of ovarian cancer cells\u2019 growth, invasion and cisplatin resistance, and established a mechanism of resistin action that included induction of EMT and stemness, as evidenced by down-regulated epithelial marker e-cadherin and up-regulated mesenchymal markers vimentin\/ ZEB1 and stemness markers sox2, oct4 and nanog. The mechanism also included suppression of tumor suppressor miRNAs, let-7a, miR-200c and miR-186. Over-expression of these miRNAs significantly reversed the resistin-mediated effects on invasion and chemoresistance. We further validated our results\n                    <jats:italic>in vivo<\/jats:italic>\n                    where resistin administration significantly enhanced tumor growth in mice. Our results provide first evidence for such oncogenic effects of resistin in ovarian cancer models and a rationale for future studies to further understand the mechanistic role of resistin in ovarian cancer invasiveness, metastasis and therapy resistance.\n                  <\/jats:p>","DOI":"10.1038\/s41598-018-30978-6","type":"journal-article","created":{"date-parts":[[2018,8,15]],"date-time":"2018-08-15T07:49:46Z","timestamp":1534319386000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Novel oncogenic and chemoresistance-inducing functions of resistin in ovarian cancer cells require miRNAs-mediated induction of epithelial-to-mesenchymal transition"],"prefix":"10.1038","volume":"8","author":[{"given":"Ling","family":"Qiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Feng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Yong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Jing","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tie-Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,21]]},"reference":[{"key":"30978_CR1","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s10549-010-0792-4","volume":"123","author":"CA Sun","year":"2010","unstructured":"Sun, C. A. et al. Adipocytokine resistin and breast cancer risk. Breast cancer research and treatment 123, 869\u2013876, https:\/\/doi.org\/10.1007\/s10549-010-0792-4 (2010).","journal-title":"Breast cancer research and treatment"},{"key":"30978_CR2","doi-asserted-by":"publisher","first-page":"258","DOI":"10.18632\/oncotarget.2724","volume":"6","author":"CH Tsai","year":"2015","unstructured":"Tsai, C. H. et al. Resistin promotes tumor metastasis by down-regulation of miR-519d through the AMPK\/p38 signaling pathway in human chondrosarcoma cells. Oncotarget 6, 258\u2013270, https:\/\/doi.org\/10.18632\/oncotarget.2724 (2015).","journal-title":"Oncotarget"},{"key":"30978_CR3","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.cca.2012.01.019","volume":"413","author":"E Danese","year":"2012","unstructured":"Danese, E. et al. The role of resistin in colorectal cancer. Clinica chimica acta; international journal of clinical chemistry 413, 760\u2013764, https:\/\/doi.org\/10.1016\/j.cca.2012.01.019 (2012).","journal-title":"Clinica chimica acta; international journal of clinical chemistry"},{"key":"30978_CR4","doi-asserted-by":"publisher","first-page":"7367485","DOI":"10.1155\/2016\/7367485","volume":"2016","author":"G Yang","year":"2016","unstructured":"Yang, G. et al. Circulating Resistin Levels and Risk of Colorectal Cancer: A Meta-Analysis. BioMed research international 2016, 7367485, https:\/\/doi.org\/10.1155\/2016\/7367485 (2016).","journal-title":"BioMed research international"},{"key":"30978_CR5","doi-asserted-by":"publisher","first-page":"124","DOI":"10.4149\/neo_2011_02_124","volume":"58","author":"M Hlavna","year":"2011","unstructured":"Hlavna, M. et al. Relationship of resistin levels with endometrial cancer risk. Neoplasma 58, 124\u2013128 (2011).","journal-title":"Neoplasma"},{"key":"30978_CR6","doi-asserted-by":"publisher","first-page":"4503","DOI":"10.7314\/APJCP.2015.16.11.4503","volume":"16","author":"TT Ilhan","year":"2015","unstructured":"Ilhan, T. T. et al. Relations of Serum Visfatin and Resistin Levels with Endometrial Cancer and Factors Associated with its Prognosis. Asian Pacific journal of cancer prevention: APJCP 16, 4503\u20134508 (2015).","journal-title":"Asian Pacific journal of cancer prevention: APJCP"},{"key":"30978_CR7","doi-asserted-by":"publisher","first-page":"619649","DOI":"10.1155\/2014\/619649","volume":"2014","author":"D Diakowska","year":"2014","unstructured":"Diakowska, D., Markocka-Maczka, K., Szelachowski, P. & Grabowski, K. Serum levels of resistin, adiponectin, and apelin in gastroesophageal cancer patients. Disease markers 2014, 619649, https:\/\/doi.org\/10.1155\/2014\/619649 (2014).","journal-title":"Disease markers"},{"key":"30978_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/1423-0127-21-59","volume":"21","author":"YY Hsieh","year":"2014","unstructured":"Hsieh, Y. Y. et al. Resistin-induced stromal cell-derived factor-1 expression through Toll-like receptor 4 and activation of p38 MAPK\/NFkappaB signaling pathway in gastric cancer cells. Journal of biomedical science 21, 59, https:\/\/doi.org\/10.1186\/1423-0127-21-59 (2014).","journal-title":"Journal of biomedical science"},{"key":"30978_CR9","doi-asserted-by":"publisher","first-page":"117955491769014","DOI":"10.1177\/1179554917690144","volume":"11","author":"G Demiray","year":"2017","unstructured":"Demiray, G., Degirmencioglu, S., Ugurlu, E. & Yaren, A. Effects of Serum Leptin and Resistin Levels on Cancer Cachexia in Patients With Advanced-Stage Non-Small Cell Lung Cancer. Clinical Medicine Insights. Oncology 11, 1179554917690144, https:\/\/doi.org\/10.1177\/1179554917690144 (2017).","journal-title":"Clinical Medicine Insights. Oncology"},{"key":"30978_CR10","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1038\/bjc.2017.282","volume":"117","author":"L Santo","year":"2017","unstructured":"Santo, L. et al. Circulating resistin levels and risk of multiple myeloma in three prospective cohorts. British journal of cancer 117, 1241\u20131245, https:\/\/doi.org\/10.1038\/bjc.2017.282 (2017).","journal-title":"British journal of cancer"},{"key":"30978_CR11","doi-asserted-by":"publisher","first-page":"E77","DOI":"10.1111\/j.1464-410X.2010.09813.x","volume":"108","author":"HJ Kim","year":"2011","unstructured":"Kim, H. J. et al. Expression of resistin in the prostate and its stimulatory effect on prostate cancer cell proliferation. BJU international 108, E77\u201383, https:\/\/doi.org\/10.1111\/j.1464-410X.2010.09813.x (2011).","journal-title":"BJU international"},{"key":"30978_CR12","doi-asserted-by":"publisher","first-page":"544.e525","DOI":"10.1016\/j.urolonc.2017.05.005","volume":"35","author":"J Kallio","year":"2017","unstructured":"Kallio, J. et al. Resistin and interleukin 6 as predictive factors for recurrence and long-term prognosis in renal cell cancer. Urologic oncology 35, 544.e525\u2013544.e531, https:\/\/doi.org\/10.1016\/j.urolonc.2017.05.005 (2017).","journal-title":"Urologic oncology"},{"key":"30978_CR13","first-page":"574","volume":"7","author":"Z Liu","year":"2017","unstructured":"Liu, Z. et al. Resistin confers resistance to doxorubicin-induced apoptosis in human breast cancer cells through autophagy induction. American journal of cancer research 7, 574\u2013583 (2017).","journal-title":"American journal of cancer research"},{"key":"30978_CR14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.canlet.2017.03.010","volume":"396","author":"SK Deshmukh","year":"2017","unstructured":"Deshmukh, S. K. et al. Resistin potentiates chemoresistance and stemness of breast cancer cells: Implications for racially disparate therapeutic outcomes. Cancer letters 396, 21\u201329, https:\/\/doi.org\/10.1016\/j.canlet.2017.03.010 (2017).","journal-title":"Cancer letters"},{"key":"30978_CR15","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.3324\/haematol.2016.154062","volume":"102","author":"J Pang","year":"2017","unstructured":"Pang, J. et al. Resistin induces multidrug resistance in myeloma by inhibiting cell death and upregulating ABC transporter expression. Haematologica 102, 1273\u20131280, https:\/\/doi.org\/10.3324\/haematol.2016.154062 (2017).","journal-title":"Haematologica"},{"key":"30978_CR16","doi-asserted-by":"publisher","first-page":"281","DOI":"10.5604\/01.3001.0010.3813","volume":"71","author":"G Slomian","year":"2017","unstructured":"Slomian, G. et al. Chemotherapy and plasma adipokines level in patients with colorectal cancer. Postepy Hig Med Dosw (Online) 71, 281\u2013290 (2017).","journal-title":"Postepy Hig Med Dosw (Online)"},{"key":"30978_CR17","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nrc2644","volume":"9","author":"RC Bast Jr","year":"2009","unstructured":"Bast, R. C. Jr, Hennessy, B. & Mills, G. B. The biology of ovarian cancer: new opportunities for translation. Nat Rev Cancer 9, 415\u2013428, https:\/\/doi.org\/10.1038\/nrc2644 (2009).","journal-title":"Nat Rev Cancer"},{"key":"30978_CR18","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.fertnstert.2003.06.021","volume":"81","author":"D Panidis","year":"2004","unstructured":"Panidis, D. et al. Serum resistin levels in women with polycystic ovary syndrome. Fertility and sterility 81, 361\u2013366, https:\/\/doi.org\/10.1016\/j.fertnstert.2003.06.021 (2004).","journal-title":"Fertility and sterility"},{"key":"30978_CR19","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1016\/j.fertnstert.2004.04.050","volume":"82","author":"N Xita","year":"2004","unstructured":"Xita, N. et al. A polymorphism in the resistin gene promoter is associated with body mass index in women with polycystic ovary syndrome. Fertility and sterility 82, 1466\u20131467, https:\/\/doi.org\/10.1016\/j.fertnstert.2004.04.050 (2004).","journal-title":"Fertility and sterility"},{"key":"30978_CR20","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1631\/jzus.2005.B0897","volume":"6","author":"XE Lu","year":"2005","unstructured":"Lu, X. E. et al. Resistin levels of serum and follicular fluid in non-obese patients with polycystic ovary syndrome during IVF cycles. Journal of Zhejiang University. Science. B 6, 897\u2013902, https:\/\/doi.org\/10.1631\/jzus.2005.B0897 (2005).","journal-title":"Science. B"},{"key":"30978_CR21","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1093\/humrep\/deh010","volume":"19","author":"KM Seow","year":"2004","unstructured":"Seow, K. M. et al. Serum and adipocyte resistin in polycystic ovary syndrome with insulin resistance. Human reproduction (Oxford, England) 19, 48\u201353 (2004).","journal-title":"Human reproduction (Oxford, England)"},{"key":"30978_CR22","first-page":"621","volume":"24","author":"Y Wang","year":"2004","unstructured":"Wang, Y., Sun, Y. & Qiu, H. Expression of resistin mRNA in adipose tissue of rat model with polycystic ovarian syndrome and its implication. Journal of Huazhong University of Science and Technology. Medical sciences\u2009=\u2009Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban\u2009=\u2009Huazhong keji daxue xuebao. Yixue Yingdewen ban 24, 621\u2013624 (2004).","journal-title":"Yixue Yingdewen ban"},{"key":"30978_CR23","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1080\/09513590902972042","volume":"25","author":"T Baba","year":"2009","unstructured":"Baba, T. et al. The contributions of resistin and adiponectin gene single nucleotide polymorphisms to the genetic risk for polycystic ovary syndrome in a Japanese population. Gynecological endocrinology: the official journal of the International Society of Gynecological Endocrinology 25, 498\u2013503, https:\/\/doi.org\/10.1080\/09513590902972042 (2009).","journal-title":"Gynecological endocrinology: the official journal of the International Society of Gynecological Endocrinology"},{"key":"30978_CR24","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1007\/s11596-009-0521-6","volume":"29","author":"Y Chu","year":"2009","unstructured":"Chu, Y., Cui, Q., Feng, G., Song, Z. & Jiang, X. The expression of resistin in adipose tissues of patients with polycystic ovary syndrome and insulin resistance. Journal of Huazhong University of Science and Technology. Medical sciences\u2009=\u2009Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban\u2009=\u2009Huazhong keji daxue xuebao. Yixue Yingdewen ban 29, 642\u2013645, https:\/\/doi.org\/10.1007\/s11596-009-0521-6 (2009).","journal-title":"Medical sciences\u2009=\u2009Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban\u2009=\u2009Huazhong keji daxue xuebao. Yixue Yingdewen ban"},{"key":"30978_CR25","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2217\/bmm.13.99","volume":"8","author":"M Dalamaga","year":"2014","unstructured":"Dalamaga, M. Resistin as a biomarker linking obesity and inflammation to cancer: potential clinical perspectives. Biomarkers in medicine 8, 107\u2013118, https:\/\/doi.org\/10.2217\/bmm.13.99 (2014).","journal-title":"Biomarkers in medicine"},{"key":"30978_CR26","doi-asserted-by":"publisher","first-page":"57694","DOI":"10.18632\/oncotarget.11034","volume":"7","author":"WJ Gong","year":"2016","unstructured":"Gong, W. J. et al. Circulating resistin levels and obesity-related cancer risk: A meta-analysis. Oncotarget 7, 57694\u201357704, https:\/\/doi.org\/10.18632\/oncotarget.11034 (2016).","journal-title":"Oncotarget"},{"key":"30978_CR27","doi-asserted-by":"publisher","first-page":"960","DOI":"10.3892\/ol.2012.865","volume":"4","author":"CY Jiang","year":"2012","unstructured":"Jiang, C. Y., Wang, W., Yin, Y. L., Yuan, Z. R. & Wang, L. B. Expression of the adipocytokine resistin and its association with the clinicopathological features and prognosis of pancreatic ductal adenocarcinoma. Oncology letters 4, 960\u2013964, https:\/\/doi.org\/10.3892\/ol.2012.865 (2012).","journal-title":"Oncology letters"},{"key":"30978_CR28","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.ygyno.2012.02.032","volume":"125","author":"YC Lee","year":"2012","unstructured":"Lee, Y. C. et al. Resistin expression in breast cancer tissue as a marker of prognosis and hormone therapy stratification. Gynecologic oncology 125, 742\u2013750, https:\/\/doi.org\/10.1016\/j.ygyno.2012.02.032 (2012).","journal-title":"Gynecologic oncology"},{"key":"30978_CR29","doi-asserted-by":"publisher","first-page":"9751","DOI":"10.3390\/ijms14059751","volume":"14","author":"L Pang","year":"2013","unstructured":"Pang, L., Zhang, Y., Yu, Y. & Zhang, S. Resistin promotes the expression of vascular endothelial growth factor in ovary carcinoma cells. International journal of molecular sciences 14, 9751\u20139766, https:\/\/doi.org\/10.3390\/ijms14059751 (2013).","journal-title":"International journal of molecular sciences"},{"key":"30978_CR30","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1055\/s-2004-826015","volume":"36","author":"A Schaffler","year":"2004","unstructured":"Schaffler, A. et al. Identification of variables influencing resistin serum levels in patients with type 1 and type 2 diabetes mellitus. Horm Metab Res 36, 702\u2013707, https:\/\/doi.org\/10.1055\/s-2004-826015 (2004).","journal-title":"Horm Metab Res"},{"key":"30978_CR31","first-page":"416","volume":"3","author":"A Salageanu","year":"2010","unstructured":"Salageanu, A. et al. Serum levels of adipokines resistin and leptin in patients with colon cancer. J Med Life 3, 416\u2013420 (2010).","journal-title":"J Med Life"},{"key":"30978_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/srep18923","volume":"6","author":"JO Lee","year":"2016","unstructured":"Lee, J. O. et al. Resistin, a fat-derived secretory factor, promotes metastasis of MDA-MB-231 human breast cancer cells through ERM activation. Scientific reports 6, 18923, https:\/\/doi.org\/10.1038\/srep18923 (2016).","journal-title":"Scientific reports"},{"key":"30978_CR33","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1002\/1873-3468.12655","volume":"591","author":"S Singh","year":"2017","unstructured":"Singh, S., Chouhan, S., Mohammad, N. & Bhat, M. K. Resistin causes G1 arrest in colon cancer cells through upregulation of SOCS3. FEBS letters 591, 1371\u20131382, https:\/\/doi.org\/10.1002\/1873-3468.12655 (2017).","journal-title":"FEBS letters"},{"key":"30978_CR34","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/onc.2017.357","volume":"37","author":"CH Wang","year":"2018","unstructured":"Wang, C. H. et al. Resistin facilitates breast cancer progression via TLR4-mediated induction of mesenchymal phenotypes and stemness properties. Oncogene 37, 589\u2013600, https:\/\/doi.org\/10.1038\/onc.2017.357 (2018).","journal-title":"Oncogene"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-30978-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-30978-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-30978-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T03:51:59Z","timestamp":1671594719000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-30978-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,21]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["30978"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-30978-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,21]]},"assertion":[{"value":"25 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"12522"}}